Objective: Despite strong pharmacological evidence implicating the norepinephrine transporter in ADHD, genetic studies have yielded largely insignificant results. We tested the association between 30 tag SNPs within the SLC6A2 gene and ADHD, with stratification based on maternal smoking during pregnancy, an environmental factor strongly associated with ADHD.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent psychiatric disorder, with rates ranging from 5.9-7.1% in children and adolescents [1] . It is heterogeneous in its clinical expression, with core symptoms of poor sustained attention, impulsivity, and hyperactivity. It is often associated with cognitive deficits, particularly in executive function and sustained attention. ADHD has an important genetic component, with a mean heritability estimate of 76%, [2] and it has been suggested that multiple genes are involved, each having a small effect. [3] .
Psychostimulants, mostly methylphenidate (MPH) [4] are the first-line of treatment for ADHD. These medications are known to block the dopamine (DA) and norepinephrine (NE) transporters, resulting in increased synaptic concentration of both neurotransmitters. [5, 6, 7] Short-term trials have concluded that MPH is efficacious in reducing ADHD symptoms in approximately 70% of affected children [4] and adults. [8] NE-specific pharmacological agents (including clonidine, guanfacine, desipramine, and atomoxetine) are effective in treating ADHD, thereby implicating this catecholamine as a major player in the pathophysiology of the disorder. [9] These studies reinforced the early evidence from neurochemical research that NE is involved in ADHD. [10, 11] Neuroimaging [12] and animal studies [13] have provided further evidence for the role of NE in ADHD.
The NE transporter protein is a pivotal player in the regulation of catecholamines, involved in the re-uptake of both NE and DA into presynaptic terminals. Thus, it plays a key role in controlling the intensity and duration of signal transduction. The NE transporter is a member of the sodium-and chloride-dependent neurotransmitter transporter family, a transmembrane glycoprotein. [14] It is encoded by SLC6A2 which has been mapped to 16 q12.2. [15] The gene includes 14 exons spanning 45 kb, [16] predicting a protein of 617 amino acids. [17] Given the clinical efficacy of agents that block the NE transporter (including psychostimulants, MPH and amphetamine, and the NE-specific agent, atomoxetine), there has been considerable interest in SLC6A2 as a candidate in genetic and pharmacogenetic studies of ADHD. Importance of the NE transporter has been further emphasized since it is responsible for the reuptake of both NE and DA in the prefrontal cortex (PFC), a brain region critical for attention regulation and where there is a scarcity of the dopamine transporter [18, 19] , thus pointing to a potentially greater role of the norepinephrine transporter.
Several family-based [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30] and case-control [22, 24, 29, 30, 31, 32, 33] studies have investigated the association between specific polymorphisms within SLC6A2 and ADHD. While initial studies were conducted with a limited number of single nucleotide polymorphisms (SNPs) [20, 22, 25, 27] , recent association studies have used arrays of SNPs covering the entire gene. [21, 23, 26, 29, 30] A number of studies have examined the association between a functional SNP in the promoter region of the gene [23081(A/T), rs28386840] and ADHD. [24, 28, 31, 32, 33] Furthermore, association between SLC6A2 and ADHD endophenotypes, including neurocognitive measures [34, 35] or quantitative symptom scores, [36] has also been studied.
Although many studies have been conducted thus far, findings have been limited and difficult to replicate. An earlier study reported an association between rs3785157 and rs998424 and ADHD. [22] Later, an independent group reported a trend for association with both these SNPs, however opposite alleles were conferring risk for the disorder in this study. [30] Although these results were not confirmed in the International Multi-centre ADHD Gene (IMAGE) project, associations were reported with two other SNPs (rs3785143, rs11568324), [23] and these were confirmed in two independent samples. [26, 29] Several related groups have reported an association between ADHD and a functional promoter SNP rs28386840 [23081(A/T)], using a case-control study design. [31, 32, 33] However, two large familybased studies (one with more than 99% power), conducted by independent groups, failed to replicate this association. [24, 28] .
Although several pharmacogenetic studies, including a genomewide association study, [37] have examined the association between SLC6A2 SNPs and response to MPH [38, 39, 40] (or OROS-MPH [41, 42] ) treatment, only limited association was observed with a few polymorphisms (rs5569, rs28386840, rs17841329, and rs192303) with little replication between studies.
We have conducted a family-based study to test the association between a panel of 30 SNPs within SLC6A2 and ADHD. In addition to the DSM-IV diagnosis of ADHD, quantitative behavioral and cognitive phenotypes, as well as response of these measures with MPH treatment, were tested for association. The panel of SNPs included those analyzed in the IMAGE project (excluding SNPs having a minor allele frequency #0.02), [23] two SNPs selected to extend the 39 flanking region examined (rs15534, rs7188230), and the functional promoter SNP, rs28386840.
Given that high comorbidity between ADHD and cigarette smoking (35%-45%) is well documented [43] , and that children with ADHD are consistently reported to have higher exposure to cigarette smoking during pregnancy compared to the general population (OR = 2.39), [44] analyses were conducted based on stratification by maternal smoking during pregnancy (MSDP). Also, it has been suggested that shared pathways to the two pathologies may exist, at least in some groups of individuals, [45] and more precisely, with respect to monoamine dysregulation. The aim of the current study was to examine the differential association (if any) of genetic polymorphisms within SLC6A2 after MSDP stratification.
Methods

Ethics Statement
The study was approved by the Douglas Mental Health University Institute (DMHUI) Research and Ethics Board. All participating children agreed to take part in the study, and parents provided written consent.
Subjects
Four hundred and seventy-five children with ADHD between 6 and 12 years of age [mean = 9; SD = 1.8] were included in this study. They were referred by schools, social workers, family doctors and pediatricians, and were recruited from the Disruptive Behavior Disorders Program and the children's outpatient clinics of the DMHUI, a psychiatric teaching hospital in Montreal, Canada.
Each child was diagnosed with ADHD according to DSM-IV criteria. Further details pertaining to diagnostic procedures have previously been described. [46, 47] Of the total number of affected children, 77.9% were male and 82.5% were of Caucasian ethnicity. 54.1% met DSM-IV criteria for the combined subtype, while 35.6% and 10.3% were diagnosed with the inattentive and hyperactive subtypes, respectively. Among comorbid disorders, 40.6% had oppositional defiant disorder, 22.9% had conduct disorder, 46.2% had anxiety disorder (including specific phobias), and 8.8% had a mood disorder (either/or major depressive episode, dysthymic disorder, manic episode, hypomanic episode).
Evaluations
The Conners' Global Index for Parents (Conners'-P) and for Teachers (Conners'-T) [48, 49] were used to evaluate the behavior of the child at home and in the classroom, respectively. The Conners' Global Index scale has been validated from a genetic point of view, with research showing that genetic factors account for up to 78% of its variance. [50] Parents were also asked to complete the Child Behavior Checklist (CBCL), a comprehensive rating scale (113-item questionnaire) with well-established metric characteristics and representative norms. [51] The raw scores of these scales were transformed into standardized T scores with an average of 50; where a score higher than 65 is considered to be clinical. The mean (standard deviation) for the total CBCL, Conners'-P, and Conners'-T scores were: 68.6 (8.9), 73.1 (11.4), and 69.5 (12.7), respectively, in this sample of children. Since it has been shown that a low to moderate correlation exists between parent and teacher reports of ADHD symptoms, and that each may assess a different dimension of the child's behavior [52, 53, 54] , by collecting information from both parents and teachers, a comprehensive assessment of the child's behavior was obtained.
In addition to clinical dimensions of ADHD, neuropsychological measures, mainly of executive function (EF), were included as quantitative traits in the genetic association analyses. EF encap-sulates the range of cognitive abilities that are important for selfregulation and goal-directed behaviors, including response inhibition, sustained attention, working memory, set-shifting, planning, and organization. Deficits in EF have been implicated in the underlying pathophysiology of ADHD. [55] The following tests were included in the neuropsychological battery: Wisconsin Card Sorting Test (WCST; measure of cognitive flexibility and setshifting), [56] Tower of London test (TOL; planning, organization, and problem-solving capacity), [57] Self-Ordered Pointing Task (SOPT; visual working memory, planning and response inhibition), [58] Conners' Continuous Performance Test (CPT; attention, response inhibition, and impulse control)_ENREF_57 [59] and Finger Windows (FW; visual-spatial working memory). [60] The WCST, TOL, SOPT, and CPT were performed as described elsewhere. [61, 62] FW is a subtest of the Wide Range Assessment of Memory and Learning (WRAML). In this test, the child is required to repeat a sequential placement of a pencil into a series of holes on a plastic card, as conducted by the examiner. When children were medicated prior to their inclusion in the study, clinical and neuropsychological assessments were carried out at the end of a one-week washout period to limit variability due to medication effects. [63] In addition to these EF measures, IQ (full scale, verbal, and performance) was evaluated using the Wechsler Intelligence Scale (WISC-III/IV). [64] .
Response to treatment with methylphenidate (MPH) was assessed in a double-blind, placebo-controlled, within-subject (crossover) randomized control trial conducted over a two-week period, as described (trial registration number: NCT00483106).
[46] Following a one-week wash-out period, subjects received either one week of treatment with placebo (PBO) or one week of treatment with 0.5 mg/kg of MPH in a divided b.i.d. dose (0.25 mg/kg, morning and noon), and were then crossed over. At the end of each treatment week, parents and teacher were asked to evaluate the child's behavior using the Conners'-P and Conners'-T, respectively. Assessments were performed before and after the administration of PBO and MPH. In addition, the clinical staff completed the Clinical Global Impression (CGI)-overall improvement scale based on their half day of behavioral observation while the child was completing various tasks in the clinic. In this study, MPH was used as a pharmacological probe to dynamically study the genetics of ADHD, rather than a classical trial of response to medication.
The Restricted Academic Situation Scale (RASS) was used to assess task-oriented behavior. During a simulated independent academic situation within a clinic setting [65] , the child is assigned a set of math problems and the RASS (coding system) is used to record the child's behavior as well as his or her ability for sustained attention to routine, repetitive academic work in the presence of potential distractions, with no adult supervision. [66] The task has previously been described in detail. [67] Over a 15 minute period, behavioral events are recorded at 30 second intervals, according to five categories: off-task (looking away from the task sheet), playing with objects (touching any object not directly used in the task), out of seat (lifting buttocks off chair or moving chair), vocalizing (any vocal noise, whether task related or not), and fidgeting (repetitive, purposeless movements). The RASS score is the total number of recorded behavioral events, and the difference score is obtained by subtracting the score after MPH administration from the score obtained after PBO. We have previously reported results from principal component analysis of the RASS [68] showing that offtask, out-of-seat, and playing with objects consist of one factor, while vocalizing and fidgeting appear to be independent factors.
Genotyping
Families were invited to participate in the genetic component of the study, where DNA was extracted, for each parent and child, from a blood sample, buccal swab, or saliva sample, if the subject was only amenable to the latter. Of the 377 nuclear families with one or more children diagnosed with ADHD, 184 were complete trios with information from both parents, 11 were trios with two affected children, 67 were trios with information from one parent and one or more unaffected sibling, 103 were duos including the proband and one parent, while 12 were families with two affected siblings and one parent.
Tag SNPs within SLC6A2, previously examined in the IMAGE project, were genotyped [23] . Those with a very low minor allele frequency (MAF #0.02) were excluded, with one exception: rs11568324 (MAF = 0.01), since this SNP was shown to be associated with ADHD in the original IMAGE study [23] and in a subsequent replication study. [26] Another SNP (rs28386840) which encodes a functional polymorphism in the upstream promoter region of SLC6A2, was also included in the panel, since it has been associated with ADHD [32] . In order to extend the flanking region examined in SLC6A2, two SNPs (rs15534, present in exon 14; rs7188230, present in the 39 intergenic region) not genotyped in the IMAGE study, were also included in this study.
Sequenom iPlex Gold Technology [69] was used to genotype the panel of SNPs, where each plate included duplicates of two reference samples to estimate genotyping error. Genotypes for these samples were read with 100% accuracy on each of the plates. Five SNPs in the original panel in the IMAGE study (rs7201099, rs3760019, rs1362620, rs1861647, rs1566652) could not be genotyped on the Sequenom platform. Since these SNPs were in strong linkage disequilibrium (LD) with other SNPs in the panel, and were not shown to be specifically associated in any previous studies, they were excluded from subsequent analyses. The genotype distribution at each of the markers analyzed in this study did not depart from Hardy-Weinberg equilibrium. [47] By using genotype information from the current study [70] and the default definition in Haploview [71] , an LD plot was generated in Haploview v4.0. In this method, 95% confidence bounds on D' are generated for each pairwise comparison. A SNP block is formed if 95% of the informative comparisons are in strong LD with each other. As indicated by the color coded cells seen in Tables 1-6 and 8-10, three major haplotype blocks exist in SLC6A2.
Statistical Analyses
Family-based tests of association (which examine the transmission disequilibrium of a specific allele/haplotype from parent to affected offspring) were conducted using the FBAT statistical package (version 2.0.3). [72] All analyses were performed under the assumption of an additive model, with a null hypothesis of no linkage and no association. Tests were first conducted with the total sample, and then by maternal smoking during pregnancy stratification (MSDP). Of the total number of nuclear families in the study (n = 377), we had information related to MSDP for 366 families, where 206 were coded as 'non-smoking' and 160 as 'smoking'.
Results
As noted in Tables 1, 2 , and 3, marginal association was observed with several behavioral and cognitive dimensions of ADHD in the total sample. However, the most significant result was noted when FBAT analysis was conducted in the stratified group where mothers smoked during pregnancy (Table 4) . Table 1 . Association between SLC6A2 SNPs and ADHD behavioural dimensions in the total sample. Table 2 . Association between SLC6A2 SNPs and ADHD cognitive dimensions in the total sample. Standard scores were used for all WCST and TOL measures, and T-scores were used for CPT measures (excl. overall index). Three major haplotype blocks in SLC6A2 are depicted above: Block 1 (rs1362621, rs2397771, rs168924, rs2242446, rs3785143, rs192303, rs41154); Block 2 (rs36017, rs10521329, rs3785155, rs5564, rs11568324, rs2279805, rs8047672, rs5569, rs998424, rs36009); and Block 3 (rs1800887, rs2242447, rs15534). Table 3 . Association between SLC6A2 SNPs and treatment response in the total sample. Table 4 . Association between SLC6A2 SNPs and ADHD behavioural dimensions in the group where mothers smoked during pregnancy (MSDP). Table 5 . Association between SLC6A2 SNPs and ADHD cognitive dimensions in the MSDP group. Standard scores were used for all WCST and TOL measures, and T-scores were used for CPT measures (excl. overall index). Three major haplotype blocks in SLC6A2 are depicted above: Block 1 (rs1362621, rs2397771, rs168924, rs2242446, rs3785143, rs192303, rs41154); Block 2 (rs36017, rs10521329, rs3785155, rs5564, rs11568324, rs2279805, rs8047672, rs5569, rs998424, rs36009); and Block 3 (rs1800887, rs2242447, rs15534). Table 6 . Association between SLC6A2 SNPs and treatment response in the MSDP group. Whereas a marginal association was observed with rs36021 in the total sample (Z = 2.54, P = 0.01), a highly significant association was observed on every measure tested, as well as treatment response in the stratified sample. The T allele of this SNP appears to be the risk allele for ADHD, showing an association with the categorical DSM-IV diagnosis (Z = 3.74, P = 0.0002). In the quantitative FBAT analysis, the T allele was over-transmitted to the higher number of inattention (Z = 3.91, P = 0.00009), hyperactivity (Z = 3.33, P = 0.0009), and impulsivity (Z = 2.93, P = 0.003) items on the DISC-IV, higher CBCL total scores (Z = 3.95, P = 0.00008) (as well as each of the dimensional scores), higher restless-impulsive subscale scores of Conners'-T (Z = 2.72, P = 0.006) and Conners'-P (Z = 2.75, P = 0.006). Taken together, this suggests that the T allele is associated with more severe psychopathology, as assessed in the home, school, and clinic. In terms of cognitive function, the risk allele was associated with worse performance on the SOPT (Z = 3.69, P = 0.0002), CPT and WCST (Table 5 ). Since the SOPT score is not a standardized score, higher scores imply worse performance, i.e. poor spatial working memory, planning, and response inhibition. A highly significant association was observed with the CPT overall index (a weighted sum of all measures within the CPT) (Z = 3.49, P = 0.0005). The risk allele was over-transmitted to the higher scores, with higher T-scores implying worse performance. In particular, an association was noted with several dimensions evaluated in this test -hit reaction time (RT) standard error (SE) (Z = 3.5, P = 0.0005) and variability of SE (Z = 3.0, P = 0.003). High T-scores on these measures indicate highly variable reactions to the ''target'' and ''non-target'', often related to inattentiveness. [73] Highly significant association was also observed with hit RT block change (Z = 3.74, P = 0.0002) and hit SE block change (Z = 2.86, P = 0.004). Here, the higher T-scores indicate a slowing in reaction time, as well as a loss of consistency, which together suggest a loss of vigilance, as the test progresses. The risk allele was also associated with poor performance on the WCST, which measures cognitive flexibility and set-shifting. The T allele showed an under-transmission (negative Z score) to the higher scores, specifically with non-perseverative errors (the higher standard Table 8 . Association between SLC6A2 SNPs and ADHD behavioural dimensions in the sample where mothers did not smoke during pregnancy. Table 9 . Association between SLC6A2 SNPs and ADHD cognitive dimensions in the sample where mothers did not smoke during pregnancy. Table 9 . Cont. Standard scores were used for all WCST and TOL measures, and T-scores were used for CPT measures (excl. overall index). Three major haplotype blocks in SLC6A2 are depicted above: Block 1 (rs1362621, rs2397771, rs168924, rs2242446, rs3785143, rs192303, rs41154); Block 2 (rs36017, rs10521329, rs3785155, rs5564, rs11568324, rs2279805, rs8047672, rs5569, rs998424, rs36009); and Block 3 (rs1800887, rs2242447, rs15534). Table 10 . Association between SLC6A2 SNPs and treatment response in the sample where mothers did not smoke during pregnancy. scores imply a better performance on the test) (Z = -3.44, P = 0.0006). No association was observed with perseverative errors or responses. On the WCST, perseverative errors occur due to an inability to shift set, despite negative feedback. [56] Nonperseverative errors are incorrect categorizations not related to perseveration, and usually arise from distractibility as well as deficits in updating and monitoring working memory. Therefore, it appears that in the group where mothers smoked during pregnancy, children with the T allele at rs36021 exhibit EF deficits, specifically sustained attention (characterized by distractibility during the task and loss of vigilance as the test progresses), spatial working memory, planning, and response inhibition. The T allele was also associated with response to MPH treatment ( Table 6 ). The risk allele was associated with greater improvement as indexed by a higher change score (score after PBO -score after MPH) on the CGI (Z = 3.275, P = 0.001), Conners'-P (Z = 2.62, P = 0.009), as well as evaluation in the simulated academic environment, (Z = 3.58, P = 0.0003). Based on the factor structure of the RASS, [68] change scores were examined for fidgeting, vocalizing and task disengagement. Association was observed with the task disengagement factor (Z = 3.44, P = 0.0006), but not with the other factors.
FBAT analysis in the group where mothers smoked during pregnancy also showed significant association between other SNPs towards the 59end of SLC6A2 and one or more behavioral/ cognitive measures. These included: rs41154, rs187714, and to a lesser extent, rs4783899, rs2397771, and rs192303. Based on calculation of D' and r 2 in Haploview, it was noted that these markers are in strong LD with rs36021 (Table 7) , explaining the parallel association observed on several of the measures. Conversely, markers that are not in strong LD with rs36021 (such as rs36023 and rs36024) do not show an association with ADHD or any of the relevant dimensions in this sub-group.
In the sample where mothers did not smoke during pregnancy, marginal association with rs3785152 was observed on several behavioral and cognitive dimensions (Tables 8, 9, 10). In contrast, this SNP showed a highly significant association with treatment response. As with rs36021, the C allele was associated with significant improvement on behavioral evaluations; CGI [PBO -MPH] (Z = 3.5, P = 0.0005), RASS task-disengagement (PBO -MPH) (Z = 3.58, P = 0.0003). No association was observed with rs36021 in this group. It is interesting that two adjacent SNPs (rs36021 and rs3785152) show highly divergent association in the two groups. In fact, LD between these two SNPs is low (Table 7) . Therefore, it is likely that a recombination event at or close to these two SNPs resulted in at least two distinct variants of SLC6A2. Association was also observed with rs1814269, rs5569, rs998424, and rs36009 in this group, though the significance was marginal.
Discussion
Conducting stratified analyses based on MSDP provides great insight into the complex association between SLC6A2 and ADHD. Although pharmacological, imaging, and neuropsychological studies have extensively implicated the norepinephrine transporter in ADHD, genetic studies have shown a minimal association. Although associations have been reported, non-replication between studies has resulted in a lack of overall significance when a meta-analysis was conducted. [74] Results presented here, and in an earlier report, [75] support the view that the lack of replication between studies may be explained, at least in part, by the inherent clinical and etiological complexity of the disorders.
The association between MSDP and ADHD is one of the most investigated in the field of environmental psychiatric epidemiology. Although consistently replicated [76, 77, 78] and high in magnitude, there is now relative consensus that this association has little causal significance [79, 80] and may instead be driven by other variables that are shared by the behavior of smoking during pregnancy in mothers and ADHD in their children. While environmental factors may play a role in this association, it is believed that genetic factors shared by mother and child play an important role in smoking during pregnancy in the former and ADHD in the latter. In this study, MSDP was used to index a subtype of ADHD with putatively more homogeneous genetic determinants shared within families of children with ADHD where mothers smoked during pregnancy. Consistent with this hypothesis, we have reported [81] that children in this subgroup present a more severe clinical picture with greater behavioral problems and lower cognitive function, when compared to children whose mothers did not smoke during pregnancy, and that this difference in clinical phenotype is significant even when important environmental factors are controlled for. The results of the current study emphasize the genetic differences in these two subtypes. Polymorphisms (rs36021 and linked SNPs) are important genetic determinants of behavior, cognition, and treatment response in ADHD children whose mothers smoked during pregnancy, and who may represent a more homogeneous group of ADHD patients, as previously reported. [81] In the subtype where mothers did not smoke during pregnancy, an association with a different region of the gene (towards the 39 end of SLC6A2) is observed.
Given that the association between ADHD and rs36021 (and linked SNPs) is highly significant only in those children whose mothers smoked during pregnancy may suggest a true interaction between exposure to maternal smoking and carrying the risk allele(s) in the SLC6A2 gene. Indeed, the adverse consequences of in utero exposure to the toxic effects of nicotine are well documented, from animal and human studies. [82] MSDP is associated with pre-and peri-natal complications, deficits in cognitive development as well as long-term behavioral problems. Alternatively, but not exclusively, the etiology of smoking behavior and ADHD may involve closely related, but distinct pathways. Indeed, it is possible that the complex genetic background underlying smoking behaviors in mothers (which is transmitted in part to their children), interacts with risk alleles in SLC6A2 to increase the risk for ADHD in children. Under the latter scenario, MSDP may be considered as a phenotypic index used to select a subgroup of children with relatively more homogeneous genetic etiology.
Irrespective of the precise links between these pathways, this study strongly suggests that genetic variation in the SLC6A2 is an important factor in a more severe subtype of ADHD. If replicated in independent studies, this may represent an important step towards personalized medicine in treating children with ADHD. [83] .
Results of the present study are perfectly congruent with reports by Song et al [35] and Yang et al, [40] but only in the group where mothers did not smoke during pregnancy. In this group, a significant over-transmission of the G allele to the higher difference scores was observed in the quantitative FBAT analysis on the Conners'-T (Table 10) . Most of this effect appears to arise from the restless-impulsive factor scores, observed only in the group of nonsmoking mothers. It is noted that when treatment response was assessed using the CGI-Improvement scale, two previous studies, [38, 42] as well as the current study, did not find an association with 1287(G/A) (rs5569) ( Table 10) .
Several other previously-reported associations were replicated in the present study. Three studies had reported an association with rs3785143 and rs11568324. [23, 26, 29] These markers are in complete LD with rs36021 (D' = 1; albeit with a low correlation coefficient, r 2 ; Table 7 ), indicating that the 3 SNPs are in one haplotype block not separated by a recombination event. In the total sample, rs3785143 showed marginal association with ADHD, but a significant association with all CBCL dimensional scores (Table 1) . No association was observed when stratified analyses were carried out. Similarly, no association was observed with rs11568324 despite the fact that it is in complete LD with rs36021. This is most likely a result of the low heterozygosity of these markers, which make them non-informative in the FBAT analysis (as indicated by the number of informative families in Table 1 ). Two other previously-implicated SNPs, rs998424 and rs36017, showed marginal association with dimensions of ADHD in the sample where mothers did not smoke during pregnancy and the total sample, respectively.
Kim and colleagues [31, 32, 33] reported an association between ADHD and a functional promoter SNP rs28386840 [-3081(A/T)] in several independent case-control studies. This association was not replicated in the current study, neither in the total sample, nor in the samples stratified by MSDP (Tables 1, 4, 8) . The lack of association with ADHD was also reported in two other familybased studies. [24, 28] A study examining the association between this polymorphism and treatment response reported an association with CGI-improvement scores [38] , where T-allele carriers showed a better response to MPH treatment. In the current study, only a marginal association was observed with difference scores on the restless-impulsive subscale of the Conners'-T in the group where mothers smoked during pregnancy (Table 6) .
In a previous report, [47] we investigated the association between ADHD and the panel of 30 SNPs examined in the present study, and noted that a complex pattern of association emerged between SLC6A2 SNPs/haplotypes, ADHD subtypes and gender. Gender and subtype are considered two dimensions that might help in reducing genetic heterogeneity in the ADHD syndrome. Although these results helped explain some of the discrepancies noted among previous studies, stratification according to these dimensions did not yield as strong an association with SLC6A2 as the stratification based on MSDP, which may suggest that the latter is more pertinent for future efforts to map genes implicated in ADHD.
SNPs that showed the most significant association in this study (rs36021 and rs3785152, in particular) are within introns, opening up two possibilities. The first possibility is that these intronic variants are involved in gene regulation. The second is that these polymorphisms are not the causal mutation, but are in LD with a functional variant. Fine-mapping of the region is required to identify the causal mutation(s) followed by molecular analysis to determine if the mutation affects transcriptional regulation of the gene or structure and function of the protein.
While we conducted a large number of comparisons and some correction for multiple testing is warranted, it is important to note that when we correct for multiple testing in relation to our primary hypothesis, that is association between SLC6A2 and ADHD in children stratified according to MSDP, the primary result of association (Z = 3.74, P = 0.0002) with rs36021 remains significant even if we apply the overly stringent Bonferroni correction (30 SNPs times two exposure strata, p = 0.002). In addition, the widespread exploratory associations that are observed with behaviors relevant to ADHD measured by different observers (parents, teachers, and research staff) and in different settings (school, home, clinic) with rs36021 suggest that these associations are unlikely to be chance findings. We believe that this considerable consistency of results strengthens the overall credibility of the primary results and help to understand how genetic vulnerability to ADHD is mediated through the traits and endophenotypes underlying this disorder.
To our knowledge, this is the largest study (among family-based and case-control studies) testing the association between ADHD and SLC6A2, with such detailed genotype and phenotype characterization. While collaboration between multiple research groups in large consortia is vital for genetic studies of ADHD, it has been shown that a significant amount of heterogeneity can be introduced in multicenter collaborative studies because of divergent clinical and evaluation practices. [84] This underscores the value of the current study where a relatively large sample has been collected at a single center using a highly standardized approach. It is also the largest study worldwide to use a double-blind, placebo-controlled design for evaluation of treatment response, combining extensive evaluation of executive function and behavioral domains, with genetic and environmental data. Nonetheless, these results must be considered exploratory and independent replication is awaited.
If confirmed in independent studies, these results will help to disentangle the complex etiological pathways of ADHD. In the long term, this would very likely lead to development of therapeutics targeting specific biochemical pathways in specific sub-groups of children with ADHD.
